{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:46:56Z","timestamp":1789073216796,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation, China","award":["20242BAB20419"],"award-info":[{"award-number":["20242BAB20419"]}]},{"name":"Jiangxi Provincial Natural Science Foundation, China","award":["20232BAB206177"],"award-info":[{"award-number":["20232BAB206177"]}]},{"name":"Science and Technology Plan Special Project of Ganzhou City","award":["GZ2024YLJ127"],"award-info":[{"award-number":["GZ2024YLJ127"]}]},{"name":"Science and Technology Research Project of Jiangxi Provincial Department of Education","award":["GJJ2401301"],"award-info":[{"award-number":["GJJ2401301"]}]},{"name":"Ph.D. Start-up Fund of First Affiliated Hospital & Clinical Medical College of Gannan Medical University","award":["QD202413"],"award-info":[{"award-number":["QD202413"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460613"],"award-info":[{"award-number":["82460613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ganzhou City Science and Technology Plan Project on University-Government Cooperation","award":["2025XDCE0023"],"award-info":[{"award-number":["2025XDCE0023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04206-7","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:47:10Z","timestamp":1771670830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A stimuli-responsive mitochondria-targeted nanoplatform for glioblastoma therapy: modulating the blood-brain barrier and delivering precise chemotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Weihong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"4206_CR1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","volume":"8","author":"TR Berger","year":"2022","unstructured":"Berger TR, Wen PY, Lang-Orsini M, Chukwueke UV. World health organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol. 2022;8:1493\u2013501.","journal-title":"JAMA Oncol"},{"key":"4206_CR2","first-page":"299","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70:299\u2013312.","journal-title":"CA Cancer J Clin"},{"key":"4206_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41586-023-06036-1","volume":"617","author":"S Krishna","year":"2023","unstructured":"Krishna S, Choudhury A, Keough MB, Seo K, Ni L, Kakaizada S, et al. Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023;617:599\u2013607.","journal-title":"Nature"},{"key":"4206_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108469","volume":"245","author":"MA Horowitz","year":"2024","unstructured":"Horowitz MA, Ghadiyaram A, Mehkri Y, Chakravarti S, Liu J, Fox K, et al. Surgical resection of glioblastoma in the very elderly: an analysis of survival outcomes using the surveillance, epidemiology, and end results database. Clin Neurol Neurosurg. 2024;245:108469.","journal-title":"Clin Neurol Neurosurg"},{"key":"4206_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01767-9","volume":"16","author":"G Minniti","year":"2021","unstructured":"Minniti G, Niyazi M, Alongi F, Navarria P, Belka C. Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol. 2021;16:36.","journal-title":"Radiat Oncol"},{"key":"4206_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122708","volume":"311","author":"J Li","year":"2024","unstructured":"Li J, Yang J, Jiang S, Tian Y, Zhang Y, Xu L, et al. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy. Biomaterials. 2024;311:122708.","journal-title":"Biomaterials"},{"key":"4206_CR7","doi-asserted-by":"publisher","first-page":"e2304187","DOI":"10.1002\/adma.202304187","volume":"35","author":"J Chen","year":"2023","unstructured":"Chen J, Pan J, Liu S, Zhang Y, Sha S, Guo H, et al. Fruit-derived extracellular-vesicle-engineered structural droplet drugs for enhanced glioblastoma chemotherapy. Adv Mater. 2023;35:e2304187.","journal-title":"Adv Mater"},{"key":"4206_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69.","journal-title":"Fluids Barriers CNS"},{"key":"4206_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041422","volume":"17","author":"B Lacoste","year":"2025","unstructured":"Lacoste B, Prat A, Freitas-Andrade M, Gu C. The blood-brain barrier: composition, properties, and roles in brain health. Cold Spring Harb Perspect Biol. 2025;17:a041422.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4206_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27:36\u201347.","journal-title":"CNS Neurosci Ther"},{"key":"4206_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910625","volume":"25","author":"F Shimizu","year":"2024","unstructured":"Shimizu F, Nakamori M. Blood-brain barrier disruption in neuroimmunological disease. Int J Mol Sci. 2024;25:10625.","journal-title":"Int J Mol Sci"},{"key":"4206_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1073858420985838","volume":"28","author":"B Segura-Collar","year":"2022","unstructured":"Segura-Collar B, Mata-Mart\u00ednez P, Hern\u00e1ndez-La\u00edn A, S\u00e1nchez-G\u00f3mez P, Gargini R. Blood-brain barrier disruption: a common driver of central nervous system diseases. Neuroscientist. 2022;28:222\u201337.","journal-title":"Neuroscientist"},{"key":"4206_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020386","volume":"14","author":"S Kim","year":"2025","unstructured":"Kim S, Jung UJ, Kim SR. The crucial role of the blood-brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications. J Clin Med. 2025;14:386.","journal-title":"J Clin Med"},{"key":"4206_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.32604\/or.2022.025696","volume":"29","author":"K Wang","year":"2021","unstructured":"Wang K, Zhang FT, Wen CL, Huang ZH, Hu ZH, Zhang YW, et al. Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics. Oncol Res. 2021;29:351\u201363.","journal-title":"Oncol Res"},{"key":"4206_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"4206_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cns.13788","volume":"28","author":"FT Zhang","year":"2022","unstructured":"Zhang FT, Wen LJ, Wang K, Huang ZH, Jin XY, Xiong RW, et al. Effect of axitinib regulating the pathological blood-brain barrier functional recovery for glioblastoma therapeutics. CNS Neurosci Ther. 2022;28:411\u201321.","journal-title":"CNS Neurosci Ther"},{"key":"4206_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","volume":"35","author":"UH Langen","year":"2019","unstructured":"Langen UH, Ayloo S, Gu C. Development and cell biology of the blood-brain barrier. Annu Rev Cell Dev Biol. 2019;35:591\u2013613.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4206_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-019-1689-8","volume":"17","author":"B Haileselassie","year":"2020","unstructured":"Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy. J Neuroinflammation. 2020;17:36.","journal-title":"J Neuroinflammation"},{"key":"4206_CR19","doi-asserted-by":"publisher","first-page":"e03082","DOI":"10.1002\/advs.202503082","volume":"30","author":"W Zou","year":"2025","unstructured":"Zou W, Lv Y, Li L, Zhang S, Liang J, Wu C, et al. FOXQ1 regulates brain endothelial mitochondrial function by orchestrating calcium signaling and Cristae morphology. Adv Sci (Weinh). 2025;30:e03082.","journal-title":"Adv Sci (Weinh)"},{"key":"4206_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcdb.2019.05.022","volume":"98","author":"M Abate","year":"2020","unstructured":"Abate M, Festa A, Falco M, Lombardi A, Luce A, Grimaldi A, et al. Mitochondria as playmakers of apoptosis, autophagy and senescence. Semin Cell Dev Biol. 2020;98:139\u201353.","journal-title":"Semin Cell Dev Biol"},{"key":"4206_CR21","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med. 2023;55:1595\u2013619.","journal-title":"Exp Mol Med"},{"key":"4206_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165598","volume":"21","author":"Y Luo","year":"2020","unstructured":"Luo Y, Ma J, Lu W. The significance of mitochondrial dysfunction in cancer. Int J Mol Sci. 2020;21:5598.","journal-title":"Int J Mol Sci"},{"key":"4206_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114705","volume":"162","author":"J Song","year":"2023","unstructured":"Song J, He GN, Dai L. A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes. Biomed Pharmacother. 2023;162:114705.","journal-title":"Biomed Pharmacother"},{"key":"4206_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-024-01983-5","volume":"74","author":"H Lei","year":"2025","unstructured":"Lei H, Ruan Y, Ding R, Li H, Zhang X, Ji X, et al. The role of celastrol in inflammation and diseases. Inflamm Res. 2025;74:23.","journal-title":"Inflamm Res"},{"key":"4206_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115846","volume":"168","author":"X Wang","year":"2026","unstructured":"Wang X, Li W, Liu XL, Liang J, Wang LY, Liu GX, et al. Celastrol as a neuroprotective drug: current status and challenges. Int Immunopharmacol. 2026;168:115846.","journal-title":"Int Immunopharmacol"},{"key":"4206_CR26","doi-asserted-by":"publisher","first-page":"e2307556","DOI":"10.1002\/advs.202307556","volume":"11","author":"X Li","year":"2024","unstructured":"Li X, Sr, Liu W, Jiang GN, Lian JR, Zhong Y, Zhou JL, et al. Celastrol ameliorates neuronal mitochondrial dysfunction induced by intracerebral hemorrhage via targeting cAMP-activated exchange protein-1. Adv Sci (Weinh). 2024;11:e2307556.","journal-title":"Adv Sci (Weinh)"},{"key":"4206_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/antiox9010037","volume":"9","author":"MW Lin","year":"2019","unstructured":"Lin MW, Lin CC, Chen YH, Yang HB, Huang SY. Celastrol inhibits dopaminergic neuronal death of parkinson\u2019s disease through activating mitophagy. Antioxid (Basel). 2019;9:37.","journal-title":"Antioxid (Basel)"},{"key":"4206_CR28","first-page":"1","volume":"5","author":"FF Cao","year":"2025","unstructured":"Cao FF, Zhang P, Zheng ZL, Wang P, Wang Y, Shi Q, et al. Celastrol treatment attenuates the inflammatory response in alzheimer\u2019s disease model mice. Neurol Res. 2025;5:1\u20137.","journal-title":"Neurol Res"},{"key":"4206_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.intimp.2018.11.029","volume":"66","author":"WY Dai","year":"2019","unstructured":"Dai WY, Wang XG, Teng HL, Li C, Wang B, Wang J. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Int Immunopharmacol. 2019;66:215\u201323.","journal-title":"Int Immunopharmacol"},{"key":"4206_CR30","doi-asserted-by":"publisher","first-page":"16816","DOI":"10.18632\/aging.203221","volume":"13","author":"HZ Xu","year":"2021","unstructured":"Xu HZ, Cai Y, Yu MY, Sun J, Cai J, Li JB, et al. Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis. Aging (Albany NY). 2021;13:16816\u201333.","journal-title":"Aging (Albany NY)"},{"key":"4206_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100876","volume":"8","author":"XM Cheng","year":"2021","unstructured":"Cheng XM, Gao J, Ding Y, Lu Y, Wei QC, Cui DZ, et al. Multi-functional liposome: a powerful theranostic nano-platform enhancing photodynamic therapy. Adv Sci. 2021;8:e2100876.","journal-title":"Adv Sci"},{"key":"4206_CR32","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.2147\/IJN.S539586","volume":"20","author":"P He","year":"2025","unstructured":"He P, Sun J, Tan J, Shi YN, Zhang CJ, Zhu N, et al. From physicochemical constraints to clinical prospects of Celastrol: challenges and nano delivery strategies. Int J Nanomedicine. 2025;20:10907\u201331.","journal-title":"Int J Nanomedicine"},{"key":"4206_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac166","volume":"4","author":"E Cooper","year":"2022","unstructured":"Cooper E, Woolf Z, Swanson MEV, Correia J, Schweder P, Mee E, et al. Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue. Neuro-Oncol Adv. 2022;4:vdac166.","journal-title":"Neuro-Oncol Adv"},{"key":"4206_CR34","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00424-014-1596-x","volume":"467","author":"B Gao","year":"2015","unstructured":"Gao B, Vavricka SR, Meier PJ, Stieger B. Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS. Pflugers Arch. 2015;467:1481\u201393.","journal-title":"Pflugers Arch"},{"key":"4206_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s12274-021-3686-3","volume":"15","author":"LJ Wen","year":"2022","unstructured":"Wen LJ, Peng Y, Wang K, Huang ZH, He SY, Xiong RW, et al. Regulation of pathological BBB restoration via nanostructured ROS-responsive glycolipid-like copolymer entrapping SiVEGF for glioblastoma targeted therapeutics. Nano Res. 2022;15:1455\u201365.","journal-title":"Nano Res"},{"key":"4206_CR36","doi-asserted-by":"crossref","unstructured":"Wen LJ, Wang K, Zhang FT, Tan YN, Shang XW, Zhu Y et al. AKT activation by SC79 to transiently re-open pathological blood brain barrier for improved functionalized nanoparticles therapy of glioblastoma. Biomaterials 2020:237:119793\u2013807.","DOI":"10.1016\/j.biomaterials.2020.119793"},{"key":"4206_CR37","doi-asserted-by":"publisher","first-page":"106574","DOI":"10.1016\/j.ejps.2023.106574","volume":"190","author":"FT Zhang","year":"2023","unstructured":"Zhang FT, Wen CL, Peng Y, Hu ZH, Zheng SK, Chen WL, et al. Biomimetic lipid nanoparticles for homologous-targeting and enhanced photodynamic therapy against glioma. Eur J Pharm Sci. 2023;190:106574\u201385.","journal-title":"Eur J Pharm Sci"},{"key":"4206_CR38","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","volume":"30","author":"P Bernardi","year":"2023","unstructured":"Bernardi P, Gerle C, Halestrap AP, Jonas EA, Karch J, Mnatsakanyan N, et al. Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ. 2023;30:1869\u201385.","journal-title":"Cell Death Differ"},{"key":"4206_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceca.2017.05.003","volume":"69","author":"S Marchi","year":"2018","unstructured":"Marchi S, Patergnani S, Missiroli S, Morciano G, Rimessi A, Wieckowski MR, et al. Mitochondrial and Endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium. 2018;69:62\u201372.","journal-title":"Cell Calcium"},{"key":"4206_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-0716-3786-9_16","volume":"2789","author":"A Shah","year":"2024","unstructured":"Shah A, Dobrovolskaia MA. Detection of nanoparticle-mediated change in mitochondrial membrane potential in T cells using JC-1 dye. Methods Mol Biol. 2024;2789:153\u201359.","journal-title":"Methods Mol Biol"},{"key":"4206_CR41","doi-asserted-by":"publisher","first-page":"11782","DOI":"10.3390\/ijms231911782","volume":"23","author":"I Giusti","year":"2022","unstructured":"Giusti I, Poppa G, D\u2019Ascenzo S, Esposito L, Vitale AR, Calvisi G, et al. Cancer three-dimensional spheroids mimic in vivo tumor features, displaying inner extracellular vesicles and vasculogenic mimicry. Int J Mol Sci. 2022;23:11782.","journal-title":"Int J Mol Sci"},{"key":"4206_CR42","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1039\/D1TB00407G","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Niu C. IR780-based nanomaterials for cancer imaging and therapy. J Mater Chem B. 2021;9:4079\u201397.","journal-title":"J Mater Chem B"},{"key":"4206_CR43","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.3390\/ijms22158248","volume":"22","author":"X V\u00e1squez","year":"2021","unstructured":"V\u00e1squez X, S\u00e1nchez-G\u00f3mez P, Palma V. Netrin-1 in glioblastoma neovascularization: the new partner in crime? Int J Mol Sci. 2021;22:8248.","journal-title":"Int J Mol Sci"},{"key":"4206_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4049\/jimmunol.2200573","volume":"211","author":"R Pscheid","year":"2023","unstructured":"Pscheid R, Drent E, Wienke J, Strijker JGM, Throsby M, Molenaar JJ. Three-dimensional modeling of solid tumors and their microenvironment to evaluate T cell therapy efficacy in vitro. J Immunol. 2023;211:229\u201340.","journal-title":"J Immunol"},{"key":"4206_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212200","volume":"22","author":"O Habanjar","year":"2021","unstructured":"Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: tumor application, advantages, and disadvantages. Int J Mol Sci. 2021;22:12200.","journal-title":"Int J Mol Sci"},{"key":"4206_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.molcel.2023.02.021","volume":"83","author":"H Flores-Romero","year":"2023","unstructured":"Flores-Romero H, Dadsena S, Garc\u00eda-S\u00e1ez AJ. Mitochondrial pores at the crossroad between cell death and inflammatory signaling. Mol Cell. 2023;83:843\u201356.","journal-title":"Mol Cell"},{"key":"4206_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","volume":"23","author":"M Bonora","year":"2023","unstructured":"Bonora M, Giorgi C, Pinton P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol. 2023;23:266\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"4206_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080923","volume":"14","author":"C Lonobile","year":"2025","unstructured":"Lonobile C, Di Nubila A, Simone R, Hushi M, Barbieri SS. The mitochondrial permeability transition pore in platelets: mechanisms, physiological roles, and therapeutic perspectives. Antioxidants (Basel). 2025;14(8):923.","journal-title":"Antioxidants (Basel)"},{"key":"4206_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.531","volume":"2","author":"DF Carrageta","year":"2022","unstructured":"Carrageta DF, Freire-Brito L, Oliveira PF, Alves MG. Evaluation of human spermatozoa mitochondrial membrane potential using the JC-1 dye. Curr Protoc. 2022;2:e531.","journal-title":"Curr Protoc"},{"key":"4206_CR50","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3128","volume":"9","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Bhalerao A, Cucullo L. Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe. Bio Protoc. 2019;9:e3128.","journal-title":"Bio Protoc"},{"key":"4206_CR51","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202213263","volume":"155","author":"GC Garcia","year":"2023","unstructured":"Garcia GC, Gupta K, Bartol TM, Sejnowski TJ, Rangamani P. Mitochondrial morphology governs ATP production rate. J Gen Physiol. 2023;155:e202213263.","journal-title":"J Gen Physiol"},{"key":"4206_CR52","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/2211-5463.70062","volume":"15","author":"C Giulivi","year":"2025","unstructured":"Giulivi C, Kotz R. Earthing effects on mitochondrial function: ATP production and ROS generation. FEBS Open Bio. 2025;15:1459\u201370.","journal-title":"FEBS Open Bio"},{"key":"4206_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102577","volume":"102","author":"YY Gu","year":"2024","unstructured":"Gu YY, Zhao XR, Zhang N, Yang Y, Yi Y, Shao QH, et al. Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: current insights and future directions. Ageing Res Rev. 2024;102:102577.","journal-title":"Ageing Res Rev"},{"key":"4206_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115601","volume":"25","author":"S Dithmer","year":"2024","unstructured":"Dithmer S, Blasig IE, Fraser PA, Qin Z, Haseloff RF. The basic requirement of tight junction proteins in blood-brain barrier function and their role in pathologies. Int J Mol Sci. 2024;25:5601.","journal-title":"Int J Mol Sci"},{"key":"4206_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","volume":"39","author":"MT Islam","year":"2017","unstructured":"Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73\u201382.","journal-title":"Neurol Res"},{"key":"4206_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1595","volume":"15","author":"HM Begum","year":"2023","unstructured":"Begum HM, Shen K. Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells. WIREs Mechanisms of Disease. 2023;15:e1595.","journal-title":"WIREs Mechanisms of Disease"},{"key":"4206_CR57","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41586-024-08146-w","volume":"635","author":"KW Ryu","year":"2024","unstructured":"Ryu KW, Fung TS, Baker DC, Saoi M, Park J, Febres-Aldana CA, et al. Cellular ATP demand creates metabolically distinct subpopulations of mitochondria. Nature. 2024;635:746\u201354.","journal-title":"Nature"},{"key":"4206_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","volume":"26","author":"LC T\u00e1bara","year":"2025","unstructured":"T\u00e1bara LC, Segawa M, Prudent J. Molecular mechanisms of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2025;26:123\u201346.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4206_CR59","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/1873-3468.14077","volume":"595","author":"NMB Yapa","year":"2021","unstructured":"Yapa NMB, Lisnyak V, Reljic B, Ryan MT. Mitochondrial dynamics in health and disease. FEBS Lett. 2021;595:1184\u2013204.","journal-title":"FEBS Lett"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04206-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04206-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:02:21Z","timestamp":1780131741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04206-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4206"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04206-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}